Skip to main content
Clinical Trials/NCT01619605
NCT01619605
Completed
Not Applicable

The Utility of Serum Tryptase in the Diagnosis of Shrimp- Induced Anaphylaxis

Mahidol University1 site in 1 country39 target enrollmentJune 2006

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Food (Shrimp) Allergy
Sponsor
Mahidol University
Enrollment
39
Locations
1
Primary Endpoint
Change of Serum tryptases
Status
Completed
Last Updated
13 years ago

Overview

Brief Summary

The purpose of this study was to investigate the utility of serum tryptase for the confirmation of shrimp-induced anaphylaxis.

Detailed Description

The diagnosis of anaphylaxis is based primarily on the clinical history. In some circumstances, inability to confirm the clinical diagnosis such as present with unusual manifestation, or when skin signs are absent likely contributes to underrecognition and undertreatment of the disease. Currently, products of mast cell activation (histamine and total tryptase) can be measure in clinical laboratories as markers of acute anaphylaxis events, however these tests have clinically relevant limitations. Therefore, development of laboratory tests with improved sensitivity and specificity that will support the clinical diagnosis of anaphylaxis are needed. In addition, shrimp is the major cause of seafood anaphylaxis among Thai children.

Registry
clinicaltrials.gov
Start Date
June 2006
End Date
June 2008
Last Updated
13 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • a history of shrimp allergy

Exclusion Criteria

  • severe anaphylactic reaction from seafood
  • pregnancy
  • underlying diseases such as cardiovascular, hepatobiliary, and renal diseases
  • on systemic corticosteroid or β-blocking agents

Outcomes

Primary Outcomes

Change of Serum tryptases

Time Frame: baseline and 60 minutes after the onset of symptoms

Study Sites (1)

Loading locations...

Similar Trials